2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer

BACKGROUND: Selected patients with peritoneal metastases of colorectal cancer (PM-CRC) can benefit from potentially curative cytoreductive surgery (CRS) ± hyperthermic intraperitoneal chemotherapy (HIPEC), with a median overall survival (OS) of more than 40 months. OBJECTIVE: The aims of this eviden...

Descripción completa

Detalles Bibliográficos
Autores principales: Hübner, Martin, van Der Speeten, Kurt, Govaerts, Kim, de Hingh, Ignace, Villeneuve, Laurent, Kusamura, Shigeki, Glehen, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Peritoneal Surface Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695877/
https://www.ncbi.nlm.nih.gov/pubmed/37940803
http://dx.doi.org/10.1245/s10434-023-14368-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695877/
https://www.ncbi.nlm.nih.gov/pubmed/37940803
http://dx.doi.org/10.1245/s10434-023-14368-5

Ejemplares similares